I don’t blame them, and you shouldn’t be surprised too, after all you did unearth the US$1.9B AbbVie pay to play AAV ocular deal; consisting of a US$370m upfront entry price to collaborate/peek at the goodies… That’s roughly A$500m, more than PYC’s current market cap… I don’t think any local AU companies can even come close to a partnership deal of that size, let alone that merely being the ticket price to walk into the royal show, with a limit to only pet one farm animal specie for no more than two strokes
Ann: Oppenheimer Fall Healthcare Life Sciences & MedTech Summit, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.24 |
Change
-0.060(4.62%) |
Mkt cap ! $729.0M | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.26 | $1.24 | $79.23K | 63.55K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 96565 | $1.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 15075 | 6 |
View Market Depth
| Last trade - 15.00pm 07/08/2025 (20 minute delay) ? |
| PYC (ASX) Chart |